Vycor Medical, Inc. (VYCO)
USD 0.07
(24.05%)
USD 0.07
(24.05%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 100.94 Thousand USD | 141.18% |
| 2022 | -246.07 Thousand USD | 33.31% |
| 2021 | -252.01 Thousand USD | 44.61% |
| 2020 | -664.59 Thousand USD | -1.19% |
| 2019 | -539.86 Thousand USD | 21.27% |
| 2018 | -1.14 Million USD | 18.24% |
| 2017 | -1.13 Million USD | 23.06% |
| 2016 | -1.32 Million USD | 18.38% |
| 2015 | -1.66 Million USD | 30.95% |
| 2014 | -3.53 Million USD | -23.3% |
| 2013 | -1.9 Million USD | 23.5% |
| 2012 | -2.43 Million USD | 41.91% |
| 2011 | -4.42 Million USD | -190.53% |
| 2010 | -1.87 Million USD | -54.31% |
| 2009 | -854.62 Thousand USD | 34.18% |
| 2008 | -1.44 Million USD | -203.09% |
| 2007 | -479.35 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 6090.00 USD | 121.4% |
| 2024 Q2 | 31.86 Thousand USD | 204.06% |
| 2023 Q4 | -48.95 Thousand USD | -377.32% |
| 2023 Q1 | 48.56 Thousand USD | 164.01% |
| 2023 Q2 | 111.59 Thousand USD | 129.78% |
| 2023 Q3 | -10.25 Thousand USD | -109.19% |
| 2023 FY | - USD | 141.18% |
| 2022 FY | - USD | 33.31% |
| 2022 Q1 | -37.33 Thousand USD | 74.5% |
| 2022 Q2 | -59.33 Thousand USD | -58.91% |
| 2022 Q3 | -72.57 Thousand USD | -22.32% |
| 2022 Q4 | -75.86 Thousand USD | -4.53% |
| 2021 FY | - USD | 44.61% |
| 2021 Q3 | -70 Thousand USD | -268.32% |
| 2021 Q4 | -146.42 Thousand USD | -109.17% |
| 2021 Q2 | 41.58 Thousand USD | 121.58% |
| 2021 Q1 | -192.69 Thousand USD | -18.95% |
| 2020 Q3 | -185.81 Thousand USD | -0.6% |
| 2020 Q1 | -140.15 Thousand USD | 24.75% |
| 2020 Q2 | -184.71 Thousand USD | -31.79% |
| 2020 Q4 | -161.99 Thousand USD | 12.82% |
| 2020 FY | - USD | -1.19% |
| 2019 Q3 | -174.46 Thousand USD | -16.2% |
| 2019 FY | - USD | 21.27% |
| 2019 Q1 | -144.84 Thousand USD | -24.77% |
| 2019 Q2 | -150.13 Thousand USD | -3.66% |
| 2019 Q4 | -186.25 Thousand USD | -6.76% |
| 2018 Q1 | -269.23 Thousand USD | 7.79% |
| 2018 FY | - USD | 18.24% |
| 2018 Q2 | -360.89 Thousand USD | -34.05% |
| 2018 Q4 | -116.08 Thousand USD | -34.07% |
| 2018 Q3 | -86.58 Thousand USD | 76.01% |
| 2017 Q3 | -219.29 Thousand USD | 21.85% |
| 2017 FY | - USD | 23.06% |
| 2017 Q4 | -291.98 Thousand USD | -33.15% |
| 2017 Q2 | -280.6 Thousand USD | -23.8% |
| 2017 Q1 | -226.67 Thousand USD | 43.76% |
| 2016 FY | - USD | 18.38% |
| 2016 Q4 | -403.07 Thousand USD | -61.97% |
| 2016 Q1 | -449.19 Thousand USD | -42.25% |
| 2016 Q3 | -248.85 Thousand USD | -11.72% |
| 2016 Q2 | -222.75 Thousand USD | 50.41% |
| 2015 Q1 | -523 Thousand USD | -1.94% |
| 2015 FY | - USD | 30.95% |
| 2015 Q3 | -413.96 Thousand USD | -12.1% |
| 2015 Q2 | -369.29 Thousand USD | 29.39% |
| 2015 Q4 | -315.77 Thousand USD | 23.72% |
| 2014 Q2 | -600.12 Thousand USD | 32.97% |
| 2014 Q4 | -513.03 Thousand USD | -50.62% |
| 2014 Q3 | -340.62 Thousand USD | 43.24% |
| 2014 Q1 | -895.29 Thousand USD | -79.78% |
| 2014 FY | - USD | -23.3% |
| 2013 Q2 | -513.39 Thousand USD | -1.36% |
| 2013 Q4 | -498 Thousand USD | -28.55% |
| 2013 Q3 | -387.4 Thousand USD | 24.54% |
| 2013 Q1 | -506.48 Thousand USD | 0.57% |
| 2013 FY | - USD | 23.5% |
| 2012 Q3 | -671.78 Thousand USD | -3.17% |
| 2012 Q2 | -651.16 Thousand USD | 1.09% |
| 2012 Q4 | -509.4 Thousand USD | 24.17% |
| 2012 Q1 | -658.35 Thousand USD | -5.28% |
| 2012 FY | - USD | 41.91% |
| 2011 Q1 | -683.72 Thousand USD | 1.75% |
| 2011 Q2 | -1.75 Million USD | -156.44% |
| 2011 Q3 | -1.04 Million USD | 40.33% |
| 2011 Q4 | -625.3 Thousand USD | 40.23% |
| 2011 FY | - USD | -190.53% |
| 2010 Q3 | -270.94 Thousand USD | 36.1% |
| 2010 Q2 | -423.98 Thousand USD | -42.71% |
| 2010 Q1 | -297.09 Thousand USD | 11.2% |
| 2010 FY | - USD | -54.31% |
| 2010 Q4 | -695.93 Thousand USD | -156.85% |
| 2009 FY | - USD | 34.18% |
| 2009 Q2 | -188.21 Thousand USD | 30.94% |
| 2009 Q3 | -110.32 Thousand USD | 41.38% |
| 2009 Q1 | -272.52 Thousand USD | -3.09% |
| 2009 Q4 | -334.54 Thousand USD | -203.25% |
| 2008 Q1 | -482.51 Thousand USD | 0.0% |
| 2008 Q4 | -264.36 Thousand USD | 17.01% |
| 2008 Q3 | -318.55 Thousand USD | 17.78% |
| 2008 FY | - USD | -203.09% |
| 2008 Q2 | -387.46 Thousand USD | 19.7% |
| 2007 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 136.802% |
| IR-Med Inc. | -4.89 Million USD | 102.063% |
| Polarean Imaging plc | -11.19 Million USD | 100.902% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 77.866% |
| Avitar, Inc. | -1.66 Million USD | 106.052% |
| AVITA Medical, Inc. | -39.56 Million USD | 100.255% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 108.672% |
| Össur hf. | 137.38 Million USD | 99.927% |
| Zecotek Photonics Inc. | -3.44 Million USD | 102.932% |
| QHSLab, Inc. | -91.29 Thousand USD | 210.57% |
| Wellstar International, Inc. | -1.35 Million USD | 107.441% |
| Össur hf. | 137.38 Million USD | 99.927% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 98.967% |
| Escalon Medical Corp. | -58.46 Thousand USD | 272.667% |
| Aurora Spine Corporation | -454.37 Thousand USD | 122.216% |
| BrainsWay Ltd. | -2.31 Million USD | 104.368% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 101.076% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 98.172% |
| Vivos Inc. | -2.79 Million USD | 103.614% |
| MicroPort Scientific Corporation | -347.57 Million USD | 100.029% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 151.061% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 106.05% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 126.641% |
| Nanomix Corporation | -8.13 Million USD | 101.24% |
| Theraclion SA | -2.05 Million USD | 104.922% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 114.277% |
| Positron Corporation | -1.45 Million USD | 106.951% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 105.862% |
| Lombard Medical, Inc. | -28.06 Million USD | 100.36% |
| ALR Technologies Inc. | -6.4 Million USD | 101.577% |
| Stratec SE | 39.91 Million USD | 99.747% |
| Heart Tronics, Inc. | -14.85 Million USD | 100.679% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 185.358% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 100.76% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 101.103% |
| VMS Rehab Systems, Inc. | -68.55 USD | 147354.559% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 103.229% |
| Ingen Technologies, Inc. | -8639.00 USD | 1268.457% |
| Odyssey Group International, Inc. | -2.13 Million USD | 104.721% |
| United American Healthcare Corporation | -59 Thousand USD | 271.09% |
| ECGI Holdings, Inc. | -2.99 Million USD | 103.376% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 116.044% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 119.638% |
| Urologix, Inc. | -6.34 Million USD | 101.591% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 108.145% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 113.179% |
| SS Innovations International, Inc. | -20.37 Million USD | 100.495% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 145.303% |
| Smith & Nephew plc | 1 Billion USD | 99.99% |
| NIOX Group Plc | 11.07 Million USD | 99.089% |
| Fuse Medical, Inc. | 1.83 Million USD | 94.5% |
| Broncus Holding Corporation | -25.19 Million USD | 100.401% |
| Brain Scientific Inc. | -7.93 Million USD | 101.272% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 101.075% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 648.603% |